Reichert L J, Koene R A, Wetzels J F
Department of Medicine, University Hospital Nijmegen, The Netherlands.
Am J Kidney Dis. 1998 Jan;31(1):1-11. doi: 10.1053/ajkd.1998.v31.pm9428445.
Membranous nephropathy is the most frequent cause of glomerulonephritis in adults with nephrotic syndrome. Approximately one quarter of the patients develop end-stage renal disease. Another quarter enters complete remission during follow-up. Treating all patients with membranous nephropathy with immunosuppressive drugs would unnecessarily expose at least one quarter of the patients to these toxic drugs. Identifying patients at highest risk would allow tailor-made treatment. Many risk factors have been found, such as male sex, HLA type DR3+/B8+, white race, advanced age, and tubulointerstitial changes or focal sclerosis found with renal biopsy. In addition, nephrotic syndrome, elevation of immunoglobulin G excretion or beta2-microglobulin excretion, low serum albumin, high serum cholesterol, an elevation of urinary excretion of complement activation products, impaired renal function at diagnosis, and, finally, hypertension are associated with a higher risk of renal function deterioration during follow-up. We have critically reviewed the literature and summarized the clinical significance of the above-mentioned risk factors in predicting subsequent renal function deterioration in patients with membranous nephropathy.
膜性肾病是成人肾病综合征中最常见的肾小球肾炎病因。约四分之一的患者会发展为终末期肾病。另有四分之一的患者在随访期间完全缓解。用免疫抑制药物治疗所有膜性肾病患者会使至少四分之一的患者不必要地暴露于这些有毒药物中。识别出风险最高的患者将有助于进行个性化治疗。已发现许多风险因素,如男性、HLA DR3+/B8+型、白种人、高龄以及肾活检发现的肾小管间质改变或局灶性硬化。此外,肾病综合征、免疫球蛋白G排泄或β2-微球蛋白排泄升高、血清白蛋白降低、血清胆固醇升高、补体激活产物尿排泄升高、诊断时肾功能受损,以及最后高血压与随访期间肾功能恶化的较高风险相关。我们对文献进行了严格审查,并总结了上述风险因素在预测膜性肾病患者后续肾功能恶化方面的临床意义。